Atualização da Diretriz de Ressuscitação Cardiopulmonar e Cuidados Cardiovasculares de Emergência da Sociedade



Baixar 8.81 Mb.
Pdf preview
Página504/535
Encontro30.06.2021
Tamanho8.81 Mb.
1   ...   500   501   502   503   504   505   506   507   ...   535
633


Atualização
Atualização da Diretriz de Ressuscitação Cardiopulmonar e Cuidados 
Cardiovasculares de Emergência da Sociedade Brasileira de Cardiologia – 2019
Arq Bras Cardiol. 2019; 113(3):449-663
technicians in patients with asystolic cardiac arrest. N Engl J Med. 
1993;328(19):1377-82.
316.  Madias C, Maron BJ, Alsheikh-Ali AA, Rajab M, Estes NA 3rd, Link MS. 
Precordial thump for cardiac arrest is effective for asystole but not for 
ventricular fibrillation. Heart Rhythm. 2009;6(10):1495-500.
317.  Miller J, Tresch D, Horwitz L, Thompson BM, Aprahamian C, Darin JC. The 
precordial thump. Ann Emerg Med. 1984;13(9 Pt 2):791-4.
318.  Haman L, Parizek P, Vojacek J. Precordial thump efficacy in termination of 
induced ventricular arrhythmias. Resuscitation. 2009;80(1):14-6.
319.  Deakin CD, Nolanb JP, Soarc J, Sunded K, Kostere RW, Smith GB, et al. 
European Resuscitation Council Guidelines for Resuscitation 2010 Section 
4. Adult advanced life support. Resuscitation. 2010;81(10):1305-52.
320.  Mangrum JM, DiMarco JP. The evaluation and management of 
bradycardia. N Engl J Med. 2000;342(10):703-9.
321.  Mancini ME, Soar J, Bhanji F, Billi JE, Dennett J, Finn J, et al. Part 12: 
Education, Implementation, and Teams: 2010 International Consensus 
on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care 
Science With Treatment Recommendations. Circulation. 2010;122(16 
Suppl 2):S539-81.
322.  Nolan J, Smith G, Evans R, McCusker K, Lubas P, Parr M, et al. The United 
Kingdom pre-hospital study of active compression decompression 
resuscitation. Resuscitation. 1998;37(2):119-25.
323.  Mandal A. Que é bradicardia? [Internet] [Citado 2010 fev 22] Disponível 
em http://www. news-medical.net/health/Bradycardia-Causes-
(Portuguese).aspx.
324.  Thomsen JH, Nielsen N, Hassager C, Wanscher M, Pehrson S, Køber L, et 
al. Bradycardia during targeted temperature management: an early marker 
of lower mortality and favorable neurologic outcome in comatose out-of-
hospital cardiac arrest patients. Crit Care Med. 2016;44(2):308-18.
325.  Staer-Jensen H, Sunde K, Olasveengen TM, Jacobsen D, Drægni T, Nakstad 
ER, et al. Bradycardia during therapeutic hypothermia is associated with 
good neurologic outcome in comatose survicors of out-of-hospital cardiac 
arrest. Crit Care Med. 2014;42(11):2401-8.
326.  Furman S, Hayers D, Holmes D. A practice of cardiac pacing. New York: 
Futura Publishing; 1986.
327.  Smith I, Monk TG, White PF. Comparison of transesophageal atrial pacing 
with anticholinergic drugs for the treatment of intraoperative bradycardia. 
Anesth Analg. 1994;78(2):245-52.
328.  Brady WJ, Swart G, DeBehnke DJ, Ma OJ, Aufderheide TP. The efficacy 
of atropine in the treatment of hemodynamically unstable bradycardia 
and atrioventricular block: prehospital and emergency department 
considerations. Resuscitation. 1999;41(1):74-55. 
329.  Dauchot P, Gravenstein JS. Effects of atropine on the eletrocardiogram in 
different age groups. Clin Pharmacol Ther. 1971;12(2):274-80.
330.  Bektas F, Soyuncu S. The efficacy of transcutaneous cardiac pacing in ED. 
Am J Emerg Med. 2016;34(11):2090-3.
331.  Mehta D, Wafa S, Ward DE, Camm AJ. Relative efficacy of various 
physical manoeuvres in the termination of junctional tachycardia. Lancet. 
1988;1(8596):1181-5.
332.  Engelstein ED, Lippman N, Stein KM, Lerman BB. Mechanism-
specific effects of adenosine on atrial tachycardia. Circulation. 
1994;89(6):2645-54.
333.  Markowitz SM, Stein KM, Mittal S, Slotwiner DJ, Lerman BB. Differential 
effects of adenosine on focal and macroreentrant atrial tachycardia. J 
Cardiovasc Electrophysiol. 1999;10(4):489-502.
334.  Stock JP. Beta adrenergic blocking drugs in the clinical management of 
cardiac arrhythmias. Am J Cardiol. 1966;18(3):444-9.
335.  Steinbeck G, Hoffmann E. 'True' atrial tachycardia. Eur Heart J. 1998;19 
(Suppl E):E10-2, E48-9.
336.  Lim SH, Anantharaman V, Teo WS, Goh PP, Tan AT. Comparison of 
treatment of supraventricular tachycardia by Valsalva maneuver and 
carotid sinus massage. Ann Emerg Med. 1998;31(1):30-5.
337.  Wen ZC, Chen SA, Tai CT, Chiang CE, Chiou CW, Chang MS, et al. 
Electrophysiological mechanisms and determinants of vagal maneuvers 
for termination of paroxysmal supraventricular tachycardia. Circulation. 
1998;98(24):2716-23.
338.  Derbes VJ, Kerr A. Valsalva's maneuver and Weber's experiment. N Engl J 
Med. 1955;253(19):822-3.
339.  Smith GD, Fry MM, Morgans A, Cantwell K. Effectiveness of the Valsalva 
manoeuvre for reversion of supraventricular tachycardia. Cochrane 
Database Syst Rev. 2015 Feb 18;(2):CD009502.
340.  Davies AJ, Kenny RA. Frequency of neurologic complications following 
carotid sinus massage. Am J Cardiol. 1998;81(10):1256-7.
341.  Cheng KA.; Intravenous Adenosine versus Verapamil in Terminating 
Episodes of Paroxysmal Supraventricular Tachycardia Study Group. 
A randomized, multicenter trial to compare the safety and efficacy of 
adenosine versus verapamil for termination of paroxysmal supraventricular 
tachycardia. Zhonghua Nei Ke Za Zhi. 2003;42(11):773-6.
342.  Hood MA, Smith WM. Adenosine versus verapamil in the treatment of 
supraventricular tachycardia: a randomized double-crossover trial. Am 
Heart J. 1992;123(6):1543-9.
343.  Rankin AC, Oldroyd KG, Chong E, Dow JW, Rae AP, Cobbe SM. Adenosine 
or adenosine triphosphate for supraventricular tachycardias? Comparative 
double-blind randomized study in patients with spontaneous or inducible 
arrhythmias. Am Heart J. 1990;119(2 Part 1):316-23.
344.  Biaggioni I, Olafsson B, Robertson RM, Hollister AS, Robertson D. 
Cardiovascular and respiratory effects of adenosine in conscious man: 
evidence for chemoreceptor activation. Circ Res. 1987;61(6):779-86.
345.  Kaplan IV, Kaplan AV, Fisher JD. Adenosine induced atrial fibrillation 
precipitating polymorphic ventricular tachycardia. Pacing Clin 
Electrophysiol. 2000;23(1):140-1.
346.  Gupta AK, Shah CP, Maheshwari A, Thakur RK, Hayes OW, Lokhandwala 
YY. Adenosine induced ventricular fibrillation in Wolff-Parkinson-White 
syndrome. Pacing Clin Electrophysiol. 2002;25(4 Pt 1):477-80.
347.  Ross DL, Uther JB. Diagnosis of concealed accessory pathways in 
supraventricular tachycardia. Pacing Clin Electrophysiol. 1984;7(6 Pt 
1):1069-85.
348.  Poutiainen AM, Koistinen MJ, Airaksinen KE, Hartikainen EK, Kettunen 
RV, Karjalainen JE, et al. Prevalence and natural course of ectopic atrial 
tachycardia. Eur Heart J. 1999;20(9):694-700.
349.  Olshansky B, Rosenfeld LE, Warner AL, et al. The Atrial Fibrillation Follow-
up Investigation of Rhythm Management (AFFIRM) study: approaches to 
control rate in atrial fibrillation. J Am Coll Cardiol. 2004;43(7):1201-8.
350.  Gupta A, Naik A, Vora A, Lokhandwala Y. Comparison of efficacy of 
intravenous diltiazem and esmolol in terminating supraventricular 
tachycardia. J Assoc Physicians India. 1999;47(10):969-72.
351.  Olukotun AY, Klein GJ. Efficacy and safety of intravenous nadolol for 
supraventricular tachycardia. Am J Cardiol. 1987;60(6):59D-62D.
352.  Anderson S, Blanski L, Byrd RC, Das G, Engler R, Laddu A, et al. Comparison 
of the efficacy and safety of esmolol, a short-acting beta blocker, with 
placebo in the treatment of supraventricular tachyarrhythmias. Am Heart 
J. 1986;111(1):42-8.
353.  Wesley RC Jr, Haines DE, Lerman BB, DiMarco JP, Crampton RS. Effect 
of intravenous magnesium sulfate on supraventricular tachycardia. Am J 
Cardiol. 1989;63(15):1129-31.
354.  Joshi PP, Deshmukh PK, Salkar RG. Efficacy of intravenous magnesium 
sulphate in supraventricular tachyarrhythmias. J Assoc Physicians India. 
1995;43(8):529-31.



Compartilhe com seus amigos:
1   ...   500   501   502   503   504   505   506   507   ...   535


©historiapt.info 2019
enviar mensagem

    Página principal